- ￥4520
- 义翘神州
- 北京
- 40789-V08H
- 2025年08月12日
企业认证
相关产品推荐更多 >
重组蛋白|Recombinant Vaccinia Virus D8L Protein (His Tag)
￥5820
重组单疱病毒gH & gL Heterodimer蛋白 (Strep II & His 标签)
询价
Recombinant Human cytomegalovirus(HCMV)Glycoprotein B/gB Protein(ECD,Fc Tag) | 重组巨细胞病毒 (HCMV)Glycoprotein B/gB 蛋白(ECD,Fc标签)
￥5820
Influenza A H5N8 (A/turkey/Germany-MV/R2472/2014 ) Hemagglutinin / HA1 Protein (His Tag)
￥4520Influenza A H3N2 (A/Switzerland/9715293/2013) Hemagglutinin / HA Protein (His Tag)
￥4520
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20℃ to -80℃
- 保质期：
12个月
- 英文名：
Influenza A H3N2 (A/Cambodia/e0826360/2020) Hemagglutinin / HA Protein (His Tag)
- 库存：
99
- 供应商：
北京义翘神州科技股份有限公司
- 规格：
100 µg
蛋白名称：Influenza A H3N2 (A/Cambodia/e0826360/2020) HA重组蛋白
蛋白构建：A DNA sequence encoding the Influenza A virus (A/Cambodia/e0826360/2020 (H3N2)) hemagglutinin (translated amino acid of EPI1837753) (Met1-Asp529), termed as HA, was expressed with a polyhistidine tag at the C-terminus.
表达宿主：HEK293 Cells
蛋白纯度：> 95 % as determined by SDS-PAGE.
蛋白活性：见说明书
蛋白内毒素：< 1.0 EU per μg protein as determined by the LAL method.
预测N端：Gln 17
蛋白分子量：The recombinant hemagglutinin of the Influenza A virus (A/Cambodia/e0826360/2020 (H3N2)) consists of 524 amino acids and predicts a molecular mass of 58.9 kDa. it migrates as an approximately 87.6 kDa band in SDS-PAGE under reducing conditions.
蛋白NP号：EPI1837753
蛋白氨基酸序列：Met1-Asp529
蛋白标签：C-His
蛋白保存条件：Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验PCR for the Detection of Influenza Viruses in Clinical Material
). Influenza A viruses are further divided into subtypes H1N1, H2N2 and H3N2, based on differences in the hemagglutinin (HA) and neuraminidase (NA) genes. The ability of influenza viruses to undergo antigenic change in HA and NA enables the virus to evade
Genetic Engineering of Live Attenuated Influenza Viruses
The first live attenuated influenza vaccine (LAIV) was licensed in the USA in 2003; it is a trivalent vaccine composed of two type A (H1N1 and H3N2) and one type B influenza virus each at 107 fluorescent focus units (FFU). Each influenza
The Mouse as Model System to Study Host‐Pathogen Interactions in Influenza A Infections
. Sun, X., Tse, L.V., Ferguson, A.D., and Whittaker, G.R. 2010. Modifications to the hemagglutinin cleavage site control the virulence of a neurotropic H1N1 influenza virus. J. Virol. 84:8683‐8690
技术资料暂无技术资料 索取技术资料
